Premier Fund Managers Ltd

Position in JNJ — Johnson & Johnson

CIK 1673907 GUILDFORD, X0

Position in JNJ

as of Jun 30, 2026 · filed Jul 22, 2026 Compact

Position Value

$17,787,042

-$1,899,911 QoQ

Shares Held

70,036

-13.0% QoQ

Ownership

0.003%

of shares outstanding

% of Portfolio

1.62%

of 13F equity value

Holder Rank

#794

of 4,664 holders

Holding Since

Jun 2020

6 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Premier Fund Managers Ltd holds $44,281,978 across 5 Drug Manufacturers - General names. JNJ ranks #1 (40.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	JNJ	Johnson & Johnson This page	70,036	$17,787,042
2	MRK	Merck & Co., Inc.	109,020	$14,009,070
3	PFE	Pfizer Inc	454,800	$10,951,584
4	ABBV	AbbVie Inc.	3,149	$792,414
5	GILD	Gilead Sciences, Inc.	5,872	$741,868

6 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$17,787,042	70,036	-13.0%	Shares	Sole	2026-07-22
2026-03-31	$19,686,953	80,539	+92.7%	Shares	Sole	2026-05-14
2025-12-31	$8,650,510	41,800	-15.5%	Shares	Sole	2026-02-03
2024-09-30	$8,013,867	49,450	+234.1%	Shares	Sole	2024-11-08
2020-09-30	$2,203,424	14,800	-6.3%	Shares	Sole	2020-11-13
2020-06-30	$2,221,954	15,800	—	Shares	Sole	2020-08-13
No filing history on record for this holder in this stock.